Table:
begin	end	state
1	13	non-cytoplasmic
14	33	transmembrane
34	65	cytoplasmic
66	87	transmembrane
88	92	non-cytoplasmic
93	111	transmembrane
112	142	cytoplasmic
143	161	transmembrane
162	179	non-cytoplasmic
180	199	transmembrane
200	208	cytoplasmic
209	228	transmembrane
229	246	non-cytoplasmic
247	266	transmembrane
267	302	cytoplasmic
303	323	transmembrane
324	343	non-cytoplasmic
344	369	transmembrane
370	388	cytoplasmic
389	410	transmembrane
411	418	non-cytoplasmic
419	442	transmembrane
443	463	cytoplasmic

Input:
>WP_011989076.1 NCBI__GCF_000016505.1:WP_011989076.1
MEGLINALNSIDSILWGVPMIVVLFGTHIFFTFRTGFIQKKIFTGIKLSVTKDPDGEGDV
SQFGALSTALAATIGTGNIIGVATAVTLGGPGAVLWMWFTGVFGIATKYAESLISVKYRV
KTEDGTMLGGAMYALEKGLKMKWLGVIFCIFTALAAFGIGCSTQTNAVASTLHNSFGIPT
WISGIVIAIFVGAVVIGGVQSITKVCEKLVPFMAIFYVLGCLIILVMNADVLGQTVVTIV
KAAFSPQAAGGGFIGSTVAIACRYGAARGLFSNESGMGSAPIVAAAAKTKNPVRQALVSM
TGTFWDTVVICLMTGLVIVSSVIKNPAIDTKTSSLLTSAAWDQIPVIGPIIIAIALAIFA
LSTVLGWSYYGERAAEYLFGKKIIKPYRVAWVIVALIGTLVSLDLVWTIADILNALMVIP
NVIAMMVIPNVIAMFLLSGVIAAETKKYVNNLDLPSEDKEKVS

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server